Malaria Treatment Market

Malaria Treatment Market Size

Malaria Treatment Market is anticipated to exceed USD 2.01 billion by 2030 from USD 1.07 billion in 2019 at a CAGR of 5.90% throughout the forecast period, i.e., 2020-30.

Malaria can be explained as a contagious potentially fatal disease caused by the Plasmodium parasite, which is transferred to human beings by mosquitoes. Malaria is usually widespread in hot climatic conditions. Anopheles mosquito is responsible for transmitting the malaria parasite from one person to another and grows vigorously in a hot, damp climate where a puddle of water provides it suitable breeding conditions. The patients suffering from malaria develop symptoms like headache, high temperature, vomiting, and quivering, while the critical patients show symptoms like acute anemia, shortness of breath, organ malfunction, and difficulties related to the peripheral nervous system. Malaria continues to exist as a considerable stimulus of death and illness between grown-ups and youngsters. Malaria is mostly found in areas where health care facilities are scarce and awareness is less. Malaria is a treatable disease provided that potent medication is started initially. Several diagnostics, like thick and thin bloodstains, rapid antigen tests, molecular tests, antibody tests, and receptiveness tests, are conducted to detect the presence of disease and to observe for recurrence. According to the World Health Organization, Africa had the maximum number of patients with malaria in 2017 and contributed 92% of malarial cases and 93% of deaths caused by malaria globally.

Market Highlights

Malaria Treatment Market is expected to project a CAGR of 5.90% during the forecast period, 2020-2030

The Malaria Treatment Market is estimated to grow on the back of the following reasons. High occurrence and disease strain in very hot & humid and sub-tropical areas, a surge in government spending for prevention of malaria and carrying out awareness drives, boost in investment from public & private institutions for the evolution of new medicines are some factors anticipated to propel the growth of the malaria treatment market during the forecast period. Moreover, the outburst of Covid-19 infection has also increased the demand for anti-malarial drugs globally, as they have shown positive results in curing Covid-19 patients. However, the deteriorating conditions of immunity in most segments of the globe and the finite number of anti-malarial drugs present have resulted in growing problems in constructing ant malarial treatment strategies, which is likely to restrict the growth of the malaria treatment market.

Global Malaria Treatment Market: Segments

Artemisinin-Based Combination Therapies Segment to outperform during 2020-2030

Malaria Treatment Market is segmented by Drugs Class into Artemisinin-Based Combination Therapies (ACTs), Chloroquine Phosphate, Vaccines, and Others. ACTs are anticipated to grow at the highest CAGR during the forecast period as they are the first-line treatment for malaria and fight malaria parasites in different ways.

Artemether & Lumefantrine drug to overcast other segments

Based on drugs, the market is segregated into Mefloquine, Primaquine Phosphate, Quinine Sulfate, Artemether & Lumefantrine, Mosquirix, and Others. Artemether & Lumefantrine drug is the most used anti-malarial drug.  Since most parasites have developed resistance against maximum drugs, Artemether & Lumefantrine continue to cure malaria.

Medication Segment to boost the market during the forecast period

Based on treatment, the market is classified as Vaccination, Medication, Supportive Care, and Others. The Medication segment is captured a huge market share of XX% in 2019 and is anticipated to grow until the vaccine for malaria is invented. Due to the absence of any vaccine, the treatment is based on drugs and hence this segment is estimated to propel overall market growth.

A parenteral segment to drive the flu treatment market

Based on the route of administration, the malaria treatment market can be grouped into oral and parenteral. Amongst both these segments, the parenteral segment captured maximum market share in 2019 and is anticipated to show the highest CAGR in the forecast period as malaria is quite hazardous and no vaccine is available to date. To overcome the present situation instantly, drugs are needed to avoid situations from becoming severe.

Online Pharmacies to drive the overall market growth

Based on distribution channels, the malaria treatment market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. Online pharmacies hold a dominant share in the market as the patients after being diagnosed at the hospitals or clinics undertake the prescribed medication from the nearby retail pharmacies. It provides efficient services with the availability of major products required to treat the disease.

Hospitals are propelling the malaria treatment market

Based on the end-users, the global malaria treatment market is categorized into hospitals, specialty clinics, home care, and others. Amongst these segments, the specialty clinics held a major market share in 2019 but the hospital segment is predicted to witness the highest CAGR during the forecast period, i.e., 2020-30. Since to cure the patients there is an urgent need to admit them to the hospitals, propelling the global malaria treatment market.

Market Dynamics

Drivers

High Prevalence of Malaria

The widespread presence of malaria in tropical and subtropical regions, as these regions provide favorable breeding grounds, is a driving factor for the market growth. According to the World Health Organization (WHO), every year the maximum number of people die due to malaria, especially in Africa. Moreover, greater government expenditure, an increase in medical insurance, and other factors are driving the overall market growth. Besides these, low prices have resulted in the rising acceptance of anti-malarial drugs even in the backward regions. Owing to the cost-effectiveness, anti-malarial medicine is quite inexpensive and projected to register a high adoption rate during the forecast period.

Restraints

Poor Healthcare Facilities

One of the major restraints of the malaria treatment market is the absence of inadequate healthcare facilities in less developed and emerging economies. Malaria is a curable disease if given the right treatment in the initial stage. However, a lack of knowledge regarding the detection of symptoms of malaria due to poor infrastructural facilities in emerging economies also hampers the growth of the malaria treatment market.

Global Malaria Treatment Market: Region                          

Asia-Pacific to grow at the highest CAGR during the forecast period

The global Malaria Treatment Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia-Pacific, and Middle-East & Africa. Geographically, Asia-Pacific is likely to dominate the market due to the high prevalence of malaria in the region leading to a high adoption rate of anti-malarial drugs. Also, the rising investment by the government in public health and research & development of novel drugs is expected to boost the overall market growth during the forecast period. Additionally, as per a report published by the WHO in 2018, the maximum number of cases of malaria was discovered in the Asia Pacific and Middle-East & Africa. Also, it is projected that XX% of the population in the Middle East & Africa are bound to suffer from malaria. According to the World Health Organization, around 76% of the registered cases of malaria in 2015 were from Asia-Pacific and Middle-East & Africa.

Global Malaria Treatment Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR- the United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR- Mexico, Argentina, Brazil, and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR- UK, Germany, France, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
• Asia-Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR- India, China, South Korea, Malaysia, Japan, Indonesia, Australia, New Zealand, and Rest of Asia-Pacific
• the Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR- North Africa, Israel, GCC, South Africa, and Rest of the Middle East and Africa

Global Malaria Treatment Market: Key Players

• Pfizer Inc

Company overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• Novartis AG
• Amayris
• GlaxoSmithKline
• Lannett Company Inc.
• Concordia International Corp.
• Teva Pharmaceuticals Inc.
• Mylan Pharmaceuticals Inc.
• Baxter International Inc.
• Sanofi

Global Malaria Treatment Market Report also contains an analysis on:

Malaria Treatment Market by segment

• By Drugs Class
  • Artemisinin-Based Combination Therapies (ACTs)
  • Vaccines
  • Chloroquine Phosphate
  • Others
• By Drugs
  • Mefloquine
  • Primaquine Phosphate
  • Quinine Sulfate
  • Artemether & Lumefantrine
  • Mosquirix
  • Others
• By Treatment
  • Vaccination
  • Medication
  • Supportive Care
  • Others
• By Route of Administration
  • Parenteral
  • Oral
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By End-Users
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
• By Region
  • North America
  • Lati n America
  • Europe
  • Asia-Pacific
  • The Middle East and Africa
• Malaria Treatment Market Size
• Malaria Treatment Market Dynamics
• Supply and Demand
• Current Issues/trends/challenges
• Competition and Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Frequently Asked Questions (FAQ):